Loading…

The Oral Toxicity of Resorcinol During Pregnancy: A Case Report

Resorcinol (1,3 benzenediol; m-dihydroxybenzene: resorcin) is a pharmaceutical agent used topically in dermatological treatments such as acne and related skin conditions. It could also be used in combination with the other acne treatment agents such as sulphur. It could be very hazardous if taken or...

Full description

Saved in:
Bibliographic Details
Published in:Journal of toxicology. Clinical toxicology 2004-01, Vol.42 (5), p.663-666
Main Authors: Duran, Bulent, Gursoy, Sinan, Cetin, Meral, Demirkoprulu, Nihal, Demirel, Yeltekin, Gurelik, Bilge
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c513t-f446629052230bccc2e18396dbcd448fd2b0608b263663a89bf635e14ccfe7823
cites cdi_FETCH-LOGICAL-c513t-f446629052230bccc2e18396dbcd448fd2b0608b263663a89bf635e14ccfe7823
container_end_page 666
container_issue 5
container_start_page 663
container_title Journal of toxicology. Clinical toxicology
container_volume 42
creator Duran, Bulent
Gursoy, Sinan
Cetin, Meral
Demirkoprulu, Nihal
Demirel, Yeltekin
Gurelik, Bilge
description Resorcinol (1,3 benzenediol; m-dihydroxybenzene: resorcin) is a pharmaceutical agent used topically in dermatological treatments such as acne and related skin conditions. It could also be used in combination with the other acne treatment agents such as sulphur. It could be very hazardous if taken orally and there are limited reports on its toxic effects in human. The present work aimed to report a resorcinol poisoning case in which resorcinol was taken accidentally by a woman at 30 weeks of pregnancy. The major clinical findings were unconsciousness, drowsiness, and respiratory failure that required mechanical ventilation along with tonic-clonic seizures and hypothermia. In addition, the laboratory findings were leucocytosis, high bilirubin levels, severe metabolic acidosis, and green-colored urine. The fetus was considered dead 24 h after delivery; however, mother's prognosis was well with supportive management. It could be concluded that the basic approach to the patient with resorcinol poisoning should include the initial stabilization of immediate life-threatening problems and elimination of the toxin. This is the first report on resorcinol poisoning in pregnant women, indicating its major clinical and laboratory findings.
doi_str_mv 10.1081/CLT-200026966
format article
fullrecord <record><control><sourceid>proquest_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_16119636</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17698157</sourcerecordid><originalsourceid>FETCH-LOGICAL-c513t-f446629052230bccc2e18396dbcd448fd2b0608b263663a89bf635e14ccfe7823</originalsourceid><addsrcrecordid>eNp10D1PwzAQgGELgWj5GFlRFtgCPjtxHBaEyqdUCYTKbDmO3aZy42Ingv57jFqoGJhuee50ehE6AXwBmMPlaDxJCcaYsJKxHTQEXBZpyYt8Fw1xQSGlHPAAHYQwj4rSnO2jAeQZI8BgiK4nM508e2mTiftsVNOtEmeSVx2cV03rbHLb-6adJi9eT1vZqtVVcpOMZNDRLJ3vjtCekTbo4808RG_3d5PRYzp-fnga3YxTlQPtUpNljJES54RQXCmliAZOS1ZXqs4ybmpSYYZ5RRhljEpeVobRXEOmlNEFJ_QQna_vLr1773XoxKIJSlsrW-36IKBgJYe8iDBdQ-VdCF4bsfTNQvqVACy-i4lYTPwWi_50c7ivFrre6k2iCM42QAYlrfGxQhO2jgGU8evo-No1rXF-IT-ct7Xo5Mo6_7NE__uh-LM609J2MyW9FnPX-zaG_ef7L_S1lZs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17698157</pqid></control><display><type>article</type><title>The Oral Toxicity of Resorcinol During Pregnancy: A Case Report</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Duran, Bulent ; Gursoy, Sinan ; Cetin, Meral ; Demirkoprulu, Nihal ; Demirel, Yeltekin ; Gurelik, Bilge</creator><creatorcontrib>Duran, Bulent ; Gursoy, Sinan ; Cetin, Meral ; Demirkoprulu, Nihal ; Demirel, Yeltekin ; Gurelik, Bilge</creatorcontrib><description>Resorcinol (1,3 benzenediol; m-dihydroxybenzene: resorcin) is a pharmaceutical agent used topically in dermatological treatments such as acne and related skin conditions. It could also be used in combination with the other acne treatment agents such as sulphur. It could be very hazardous if taken orally and there are limited reports on its toxic effects in human. The present work aimed to report a resorcinol poisoning case in which resorcinol was taken accidentally by a woman at 30 weeks of pregnancy. The major clinical findings were unconsciousness, drowsiness, and respiratory failure that required mechanical ventilation along with tonic-clonic seizures and hypothermia. In addition, the laboratory findings were leucocytosis, high bilirubin levels, severe metabolic acidosis, and green-colored urine. The fetus was considered dead 24 h after delivery; however, mother's prognosis was well with supportive management. It could be concluded that the basic approach to the patient with resorcinol poisoning should include the initial stabilization of immediate life-threatening problems and elimination of the toxin. This is the first report on resorcinol poisoning in pregnant women, indicating its major clinical and laboratory findings.</description><identifier>ISSN: 0731-3810</identifier><identifier>EISSN: 1097-9875</identifier><identifier>DOI: 10.1081/CLT-200026966</identifier><identifier>PMID: 15462161</identifier><language>eng</language><publisher>Monticello, NY: Informa UK Ltd</publisher><subject>Adult ; Apgar Score ; Biological and medical sciences ; Bradycardia - physiopathology ; Cesarean Section ; Drug toxicity and drugs side effects treatment ; Fatal Outcome ; Female ; Glasgow Coma Scale ; Heart Rate, Fetal - physiology ; Humans ; Infant, Newborn ; Medical sciences ; Medication Errors ; Miscellaneous (drug allergy, mutagens, teratogens...) ; Pharmacology. Drug treatments ; Poisoning ; Pregnancy ; Resorcinol ; Resorcinols - poisoning</subject><ispartof>Journal of toxicology. Clinical toxicology, 2004-01, Vol.42 (5), p.663-666</ispartof><rights>2004 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2004</rights><rights>2004 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c513t-f446629052230bccc2e18396dbcd448fd2b0608b263663a89bf635e14ccfe7823</citedby><cites>FETCH-LOGICAL-c513t-f446629052230bccc2e18396dbcd448fd2b0608b263663a89bf635e14ccfe7823</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16119636$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15462161$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Duran, Bulent</creatorcontrib><creatorcontrib>Gursoy, Sinan</creatorcontrib><creatorcontrib>Cetin, Meral</creatorcontrib><creatorcontrib>Demirkoprulu, Nihal</creatorcontrib><creatorcontrib>Demirel, Yeltekin</creatorcontrib><creatorcontrib>Gurelik, Bilge</creatorcontrib><title>The Oral Toxicity of Resorcinol During Pregnancy: A Case Report</title><title>Journal of toxicology. Clinical toxicology</title><addtitle>J Toxicol Clin Toxicol</addtitle><description>Resorcinol (1,3 benzenediol; m-dihydroxybenzene: resorcin) is a pharmaceutical agent used topically in dermatological treatments such as acne and related skin conditions. It could also be used in combination with the other acne treatment agents such as sulphur. It could be very hazardous if taken orally and there are limited reports on its toxic effects in human. The present work aimed to report a resorcinol poisoning case in which resorcinol was taken accidentally by a woman at 30 weeks of pregnancy. The major clinical findings were unconsciousness, drowsiness, and respiratory failure that required mechanical ventilation along with tonic-clonic seizures and hypothermia. In addition, the laboratory findings were leucocytosis, high bilirubin levels, severe metabolic acidosis, and green-colored urine. The fetus was considered dead 24 h after delivery; however, mother's prognosis was well with supportive management. It could be concluded that the basic approach to the patient with resorcinol poisoning should include the initial stabilization of immediate life-threatening problems and elimination of the toxin. This is the first report on resorcinol poisoning in pregnant women, indicating its major clinical and laboratory findings.</description><subject>Adult</subject><subject>Apgar Score</subject><subject>Biological and medical sciences</subject><subject>Bradycardia - physiopathology</subject><subject>Cesarean Section</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Fatal Outcome</subject><subject>Female</subject><subject>Glasgow Coma Scale</subject><subject>Heart Rate, Fetal - physiology</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Medical sciences</subject><subject>Medication Errors</subject><subject>Miscellaneous (drug allergy, mutagens, teratogens...)</subject><subject>Pharmacology. Drug treatments</subject><subject>Poisoning</subject><subject>Pregnancy</subject><subject>Resorcinol</subject><subject>Resorcinols - poisoning</subject><issn>0731-3810</issn><issn>1097-9875</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNp10D1PwzAQgGELgWj5GFlRFtgCPjtxHBaEyqdUCYTKbDmO3aZy42Ingv57jFqoGJhuee50ehE6AXwBmMPlaDxJCcaYsJKxHTQEXBZpyYt8Fw1xQSGlHPAAHYQwj4rSnO2jAeQZI8BgiK4nM508e2mTiftsVNOtEmeSVx2cV03rbHLb-6adJi9eT1vZqtVVcpOMZNDRLJ3vjtCekTbo4808RG_3d5PRYzp-fnga3YxTlQPtUpNljJES54RQXCmliAZOS1ZXqs4ybmpSYYZ5RRhljEpeVobRXEOmlNEFJ_QQna_vLr1773XoxKIJSlsrW-36IKBgJYe8iDBdQ-VdCF4bsfTNQvqVACy-i4lYTPwWi_50c7ivFrre6k2iCM42QAYlrfGxQhO2jgGU8evo-No1rXF-IT-ct7Xo5Mo6_7NE__uh-LM609J2MyW9FnPX-zaG_ef7L_S1lZs</recordid><startdate>20040101</startdate><enddate>20040101</enddate><creator>Duran, Bulent</creator><creator>Gursoy, Sinan</creator><creator>Cetin, Meral</creator><creator>Demirkoprulu, Nihal</creator><creator>Demirel, Yeltekin</creator><creator>Gurelik, Bilge</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><general>Dekker</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20040101</creationdate><title>The Oral Toxicity of Resorcinol During Pregnancy: A Case Report</title><author>Duran, Bulent ; Gursoy, Sinan ; Cetin, Meral ; Demirkoprulu, Nihal ; Demirel, Yeltekin ; Gurelik, Bilge</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c513t-f446629052230bccc2e18396dbcd448fd2b0608b263663a89bf635e14ccfe7823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Apgar Score</topic><topic>Biological and medical sciences</topic><topic>Bradycardia - physiopathology</topic><topic>Cesarean Section</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Fatal Outcome</topic><topic>Female</topic><topic>Glasgow Coma Scale</topic><topic>Heart Rate, Fetal - physiology</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Medical sciences</topic><topic>Medication Errors</topic><topic>Miscellaneous (drug allergy, mutagens, teratogens...)</topic><topic>Pharmacology. Drug treatments</topic><topic>Poisoning</topic><topic>Pregnancy</topic><topic>Resorcinol</topic><topic>Resorcinols - poisoning</topic><toplevel>online_resources</toplevel><creatorcontrib>Duran, Bulent</creatorcontrib><creatorcontrib>Gursoy, Sinan</creatorcontrib><creatorcontrib>Cetin, Meral</creatorcontrib><creatorcontrib>Demirkoprulu, Nihal</creatorcontrib><creatorcontrib>Demirel, Yeltekin</creatorcontrib><creatorcontrib>Gurelik, Bilge</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Journal of toxicology. Clinical toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Duran, Bulent</au><au>Gursoy, Sinan</au><au>Cetin, Meral</au><au>Demirkoprulu, Nihal</au><au>Demirel, Yeltekin</au><au>Gurelik, Bilge</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Oral Toxicity of Resorcinol During Pregnancy: A Case Report</atitle><jtitle>Journal of toxicology. Clinical toxicology</jtitle><addtitle>J Toxicol Clin Toxicol</addtitle><date>2004-01-01</date><risdate>2004</risdate><volume>42</volume><issue>5</issue><spage>663</spage><epage>666</epage><pages>663-666</pages><issn>0731-3810</issn><eissn>1097-9875</eissn><abstract>Resorcinol (1,3 benzenediol; m-dihydroxybenzene: resorcin) is a pharmaceutical agent used topically in dermatological treatments such as acne and related skin conditions. It could also be used in combination with the other acne treatment agents such as sulphur. It could be very hazardous if taken orally and there are limited reports on its toxic effects in human. The present work aimed to report a resorcinol poisoning case in which resorcinol was taken accidentally by a woman at 30 weeks of pregnancy. The major clinical findings were unconsciousness, drowsiness, and respiratory failure that required mechanical ventilation along with tonic-clonic seizures and hypothermia. In addition, the laboratory findings were leucocytosis, high bilirubin levels, severe metabolic acidosis, and green-colored urine. The fetus was considered dead 24 h after delivery; however, mother's prognosis was well with supportive management. It could be concluded that the basic approach to the patient with resorcinol poisoning should include the initial stabilization of immediate life-threatening problems and elimination of the toxin. This is the first report on resorcinol poisoning in pregnant women, indicating its major clinical and laboratory findings.</abstract><cop>Monticello, NY</cop><pub>Informa UK Ltd</pub><pmid>15462161</pmid><doi>10.1081/CLT-200026966</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0731-3810
ispartof Journal of toxicology. Clinical toxicology, 2004-01, Vol.42 (5), p.663-666
issn 0731-3810
1097-9875
language eng
recordid cdi_pascalfrancis_primary_16119636
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects Adult
Apgar Score
Biological and medical sciences
Bradycardia - physiopathology
Cesarean Section
Drug toxicity and drugs side effects treatment
Fatal Outcome
Female
Glasgow Coma Scale
Heart Rate, Fetal - physiology
Humans
Infant, Newborn
Medical sciences
Medication Errors
Miscellaneous (drug allergy, mutagens, teratogens...)
Pharmacology. Drug treatments
Poisoning
Pregnancy
Resorcinol
Resorcinols - poisoning
title The Oral Toxicity of Resorcinol During Pregnancy: A Case Report
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T10%3A24%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Oral%20Toxicity%20of%20Resorcinol%20During%20Pregnancy:%20A%20Case%20Report&rft.jtitle=Journal%20of%20toxicology.%20Clinical%20toxicology&rft.au=Duran,%20Bulent&rft.date=2004-01-01&rft.volume=42&rft.issue=5&rft.spage=663&rft.epage=666&rft.pages=663-666&rft.issn=0731-3810&rft.eissn=1097-9875&rft_id=info:doi/10.1081/CLT-200026966&rft_dat=%3Cproquest_pasca%3E17698157%3C/proquest_pasca%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c513t-f446629052230bccc2e18396dbcd448fd2b0608b263663a89bf635e14ccfe7823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17698157&rft_id=info:pmid/15462161&rfr_iscdi=true